Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
- Status
- RECRUITING
- Phase
- PHASE3
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3